A Study to Evaluate the Efficacy and Safety of AK102 in Patients With Hyperlipidemia

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2021
This is a randomized, double-blind, placebo-controlled phase Ⅲ clinical study evaluating the efficacy and safety of AK102 in patients with primary hypercholesterolemia and mixed hyperlipidemia.
Epistemonikos ID: 88161f3aee29d2b6a62fbf226a01e3181b7fb4a1
First added on: May 10, 2024